Vimarsana
Biggest News Aggregation in the World

Page 3 - Pharmaceutical Development Services News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharmaceutical Development Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharmaceutical Development Services Today - Breaking & Trending Today

Health Canada approves BeiGene's Brukinsa for marginal zone lymphoma - Vimarsana News

Health Canada approves BeiGene's Brukinsa for marginal zone lymphoma

Health Canada has granted marketing approval to BeiGene’s Brukinsa to treat marginal zone lymphoma (R/R MZL) in adult individuals.

Moderna signs vaccine distribution service agreement with Adium Pharma - Vimarsana News

Moderna signs vaccine distribution service agreement with Adium Pharma

Moderna and Adium Pharma have entered a distribution service agreement to commercialise the former’s Covid-19 vaccine in Latin America.

Covid-19 update: Strain of Covid-19 combining Delta and Omicron discovered - Vimarsana News

Covid-19 update: Strain of Covid-19 combining Delta and Omicron discovered

A strain of Covid-19 that combines Delta and Omicron was found in Cyprus, according to Leondios Kostrikis, at the University of Cyprus.

Mikart acquires state-of-the-art Korsch XM12 to meet client demands for complex formulation development & production of oral solid dose products - Vimarsana News

Mikart acquires state-of-the-art Korsch XM12 to meet client demands for complex formulation development & production of oral solid dose products

/PRNewswire/ -- Mikart, LLC a comprehensive contract development and manufacturing organization recently acquired a state-of-the-art Korsch XM12 to meet their...

Lykan Bioscience Welcomes Keith McCormick as Chief Financial Officer - Vimarsana News

Lykan Bioscience Welcomes Keith McCormick as Chief Financial Officer

Lykan Bioscience Welcomes Keith McCormick as Chief Financial Officer News provided by Share this article Share this article HOPKINTON, Mass., Feb. 15, 2021 /PRNewswire/ -- Lykan Bioscience, a contract Manufacturing Services Organization™ (MSO) and provider of the first true end-to-end solution for the manufacture of cell-based therapies, welcomes Keith McCormick as Chief Financial Officer.  Keith brings more than 30 years of finance experience with leadership positions in several leading companies across a range of industries, geographies, and financial disciplines. As CFO, Keith is respo...